Literature DB >> 1336787

Replication of hepatitis C virus in peripheral blood mononuclear cells. Effect of alpha-interferon therapy.

C Qian1, J Camps, M D Maluenda, M P Civeira, J Prieto.   

Abstract

Hepatitis C virus (HCV) is a positive-stranded RNA virus which replicates through a negative-stranded RNA intermediate. Using a PCR procedure to detect positive and negative strands, we investigated the existence of HCV replication in lymphoid cells. Both positive and negative strands were found in the peripheral blood mononuclear cells (PBMC) of all patients (n = 10) with untreated chronic hepatitis C. No HCV sequences were detected in PBMC in any of the 8 healthy controls. Fifteen patients with chronic hepatitis C were studied at the end of a 12-month course of alpha-interferon therapy. The positive strand was detected in PBMC in all 9 non-responder patients, and the negative strand in 7. In contrast, in PBMC from responder patients (n = 6) the positive strand was found in 4 and the negative strand in only 2 cases. These results demonstrate that HCV can infect PBMC and replicate in these cells and that interferon seems to exert an inhibitory effect on this process. Persistence of HCV-RNA in PBMC may help explain disease relapse after successful interferon therapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1336787     DOI: 10.1016/s0168-8278(05)80674-9

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  16 in total

Review 1.  Hepatitis C virus: molecular biology and genetic variability.

Authors:  C Bréchot
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

2.  Increased serum concentrations of soluble HLA-class I antigens in hepatitis C virus related mixed cryoglobulinaemia.

Authors:  S Migliaresi; A Bresciani; L Ambrosone; M Spera; D Barbarulo; V Lombari; G Pirozzi; G Borgia; M L Lombardi; G Tirri; C Manzo
Journal:  Ann Rheum Dis       Date:  2000-01       Impact factor: 19.103

3.  Genetic heterogeneity of hypervariable region 1 of the hepatitis C virus (HCV) genome and sensitivity of HCV to alpha interferon therapy.

Authors:  K Sandres; M Dubois; C Pasquier; J L Payen; L Alric; M Duffaut; J P Vinel; J P Pascal; J Puel; J Izopet
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Use of whole blood specimens for routine clinical quantitation of hepatitis C virus RNA does not increase assay sensitivity.

Authors:  L Cook; A M Ross; G B Knight; V Agnello
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

5.  Human Interferon Regulatory Factor 2 Gene Expression is Induced in Chronic Hepatitis C Virus Infection-A Possible Mode of Viral Persistence.

Authors:  Rathindra M Mukherjee; Budhapriyavilas Bansode; Puja Gangwal; Aparna Jakkampudi; Panyala B Reddy; Padaki N Rao; Rajesh Gupta; D Nageshwar Reddy
Journal:  J Clin Exp Hepatol       Date:  2012-04-12

6.  Quantitative detection of hepatitis C virus (HCV) RNA in saliva and gingival crevicular fluid of HCV-infected patients.

Authors:  Tetsuro Suzuki; Kazuhiko Omata; Tazuko Satoh; Takahiro Miyasaka; Chiaki Arai; Munehiro Maeda; Tomonori Matsuno; Tatsuo Miyamura
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

Review 7.  Role of macrophages and monocytes in hepatitis C virus infections.

Authors:  Dennis Revie; Syed Zaki Salahuddin
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

8.  Correlation of hepatitis C antibody levels in gingival crevicular fluid and saliva of hepatitis C seropositive hemodialysis patients.

Authors:  Gökhan Açıkgöz; Murat Inanç Cengiz; Ilker Keskiner; Sereften Açıkgöz; Murat Can; Aydan Açıkgöz
Journal:  Int J Dent       Date:  2009-09-10

9.  Hepatitis C virus lymphotropism and peculiar immunological phenotype: effects on natural history and antiviral therapy.

Authors:  Paolo Conca; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2009-05-21       Impact factor: 5.742

10.  Persistence of hepatitis C virus in peripheral blood mononuclear cells of sustained viral responders to pegylated interferon and ribavirin therapy.

Authors:  Juan F Gallegos-Orozco; Jorge Rakela; Marianne J Rosati; Hugo E Vargas; Vijayan Balan
Journal:  Dig Dis Sci       Date:  2008-07-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.